-
LIV Golf to lay off majority of staff
-
US designates UK-based Palestine Action as foreign 'terrorist group'
-
How narwhal 'scientists' track Arctic warming
-
'Rocky Horror Picture Show' star Tim Curry dead at 80
-
Iran says US sanctions will achieve nothing
-
American Moll wins women's pole vault at Zurich city event
-
Essential Dolly: five key Parton songs
-
As Canada takes on US tariffs, what's behind the David and Goliath fight?
-
Veteran promoter Warren says it's Joshua's job to agree Fury fight
-
UEFA 'likely' to drop threat to boycott FIFA tournaments: source
-
Ex-champ Wawrinka gets last-minute wildcard to US Open
-
US disrupts platforms allegedly used by Chinese hackers
-
Brennan blasts to Vuelta stage five victory, Pogacar holds lead
-
The foreign tourists missing in Nepal's flash floods
-
What could change for US teens on Instagram and Facebook
-
Hundreds missing after Nepal-Tibet flood kills 98
-
Meta, US states agree $16.7 bn settlement in landmark teen safety case
-
CIA director was on 'semi-routine' mission in Moscow: Trump
-
'Point of no return' if Israel-Hamas truce fails: US envoy to Gaza board
-
Aldeguer switches to Rossi's VR46 for next season
-
Barcelona holding out hope for Alvarez as Atletico resist sale
-
Rent TRON Energy and Reduce USDT Fees : TronBid Expands Marketplace
-
Werro basks in new status, shelves world record talk
-
Pakistan captain Babar Azam returns against England '90 percent fit'
-
Bill Gates warns world unprepared for AI upheaval
-
Stocks mixed as oil drops, inflation stays high
-
Prince Harry and family arrive back in Britain: UK media
-
Improving standards transform pole vault as spectacle, says Duplantis
-
German plan for sugar tax on Coke Zero fizzles out
-
India close in on win despite Sri Lanka fightback in second Test
-
Deadly flood hits Nepal-Tibet border, hundreds unaccounted for
-
MEXC TradFi Gala Concludes With Over 170,000 Registrations and $4.3 Billion in Daily Trading Volume
-
Tongue says Root has left England in no doubt over conduct standards
-
Olympic skating champion Liu to skip new season
-
Flags lowered across US for country music legend Dolly Parton
-
Benfica sign midfielder Palhinha from Bayern
-
Stocks gain as oil drops on Mideast hopes
-
Flick says Barca may go without striker as Atletico resist Alvarez sale
-
Bouaddi joins Man City for Premier League teenage record £85.6 mn
-
Too hot to incubate: Nile crocodiles hatch on their own in French reserve
-
Reclusive Hungarian author Peter Nadas dies aged 83
-
Spurs closing in on Man City's Marmoush after signing Savio
-
Man City sign Lille's Bouaddi for 100 mn euros
-
Celtic count the cost of Champions League flop
-
Sooriyabandara, Mendis lead Sri Lanka fightback after follow-on
-
Lebanon accuses Israel of burning forest, farmland in south
-
With ropes and chants, thousands move Japanese castle
-
Nepal floods at China border kill 8, cause 'major casualties' in Tibet
-
Zurich Diamond League: five events to watch
-
France eases cow diets as cheesemakers sweat
Path Fertility Releases its SpermQT Facts Sheet
SALT LAKE CITY, UT / ACCESS Newswire / March 17, 2026 / Path FertilityTM, an epigenetics-driven fertility technology company, today unveiled its SpermQTTM Facts Sheet, a copy of which is embedded below within this news release.
BEGINNING OF Path Fertility's SpermQT Facts Sheet.
SpermQTIntroduction
SpermQT is a clinically validated epigenetic sperm quality test from Path Fertility designed to help answer a practical question in fertility care: Are sperm likely to function well enough to support pregnancy, even when Semen Analysis results look "Normal"?

Traditional Semen Analysis testing is still the "Standard of Care" in fertility circles. It measures sperm count, movement, and shape. Conversely, SpermQT adds an additional layer of insight by analyzing sperm DNA methylation patterns associated with sperm function, i.e., the presence of certain DNA abnormalities in sperm.
The Problem Addressed
Many couples spend months making decisions based on incomplete information about male fertility. Common patterns include:
Semen Analysis comes back "Normal," but pregnancy still does not happen;
A couple is labeled "unexplained infertility" and treatment escalates without more clear male-factor insights;
Couples repeat time-consuming cycles and procedures without better diagnostics to guide next steps; and
Decisions around intrauterine insemination (IUI) are made with limited ability to predict success.

PHOTO CAPTION: SpermQT overview page from Path Fertility. March 2026
Couples that Can Benefit from SpermQT
SpermQT is especially relevant for:
Couples exploring fertility options that want better clarity earlier in the process;
Couples diagnosed with unexplained infertility, including cases with "Normal" Semen Analysis results;
Couples considering intrauterine insemination (IUI), a procedure where prepared sperm is placed into the uterus during ovulation;
Couples that need clearer guidance on what to do after experiencing failed IUIs; and
Healthcare professionals and providers seeking a more complete initial male fertility workup beyond Semen Analysis alone.
What SpermQT Measures
SpermQT analyzes epigenetic patterns (DNA methylation) in sperm. These patterns are associated with the biological steps sperm must complete to support pregnancy, often described as:
Find an egg,
Bind to an egg,
Penetrate an egg, and
Fertilize an egg.
SpermQT evaluates DNA methylation dysregulation across 1,200+ genes linked to sperm function.
VIDEO CAPTION - Path Fertility's "SpermQT: A NEW KIND OF SPERM TEST" video, also found on YouTube here: https://www.youtube.com/watch?v=EHvFUEBctTs.
SpermQT Test Results
SpermQT results are delivered in three categories:
Excellent
Normal
Abnormal
Key Takeaways, in Plain English
SpermQT is designed to add functional insight that Semen Analysis does not measure.
An Abnormal SpermQT result can provide a signal that sperm function may be contributing to infertility, even when Semen Analysis results are listed as "Normal."
SpermQT is positioned as an early, complementary test to help guide decision-making around IUI planning and next-step conversations.
Key Clinical Insights
A review of the clinical data shows that SpermQT is positioned to help in three specific ways -
Prediction for IUI planning:
Published clinical data reports statistically significant differences in pregnancy and live birth outcomes across SpermQT result tiers in IUI settings.Identifying "hidden" male-factor risk missed by Semen Analysis tests:
Path Fertility states that many Abnormal SpermQT results occur in men whose semen parameters appear normal on Semen Analysis, including the commonly cited "4 out of 5" framing.IVF with ICSI context:
Published findings suggest that in certain datasets, IVF with ICSI may reduce or overcome outcome differences associated with Abnormal SpermQT results.
In Vitro Fertilization (IVF): eggs are retrieved and fertilized in a lab, then an embryo is transferred to the uterus.
Conversely, Intracytoplasmic Sperm Injection (ICSI): a technique used with IVF where a single sperm is injected directly into an egg.
When to Use SpermQT (Practical Guidance)
Consider SpermQT when:
Semen Analysis results are Normal but pregnancy is not happening;
IUIs have failed and you need more insight into whether to continue IUI or move forward;
Clearer guidance is needed before investing time and money into IUI cycles; and
A more complete male-factor picture is desired earlier in the fertility workup.
{NOTE: SpermQT is not a replacement for Semen Analysis. It is intended to complement the traditional "Standard of Care" available via traditional Semen Analysis with functional insights.}
How It Works
Sample collected, followed by
→ Lab analysis of sperm DNA methylation patterns
→ SpermQT tier result (Excellent, Normal, Abnormal)
→ Patient and provider use results to inform next steps, including IUI planning and whether IVF options should be discussed
SpermQT Ordering and Pricing
SpermQT is physician ordered, with samples collected at home or in a clinic, with results typically available within 2 weeks.
Cash-pay Price: $385
With Semen Analysis bundle: $499
{NOTE: Many organizations cover the cost of SpermQT tests through their insurance/benefits programs. Couples faced with infertility challenges are encouraged to check with their insurance providers and/or Human Resources representative(s) to learn more.}

PHOTO CAPTION: The SpermQT at-home test from Path Fertility. March 2026
Contacts
Web: PathFertility.com
Provider support: Via Path Fertility
PR/Media Contact: David Politis, [email protected], +1-801-556-8184
END OF Path Fertility's SpermQT Facts Sheet AND COMPLETION OF THE NEWS RELEASE BELOW
About Path Fertility and SpermQT
Path Fertility is focused on raising the "Standard of Care" in male fertility by providing deeper insight into sperm quality and function. As such, SpermQT is a sperm quality test based on epigenetic DNA-markers and is designed to complement Semen Analysis by adding new information related to sperm function.
Path Fertility, SpermQT, and the Path Fertility logos are trademarks of Inherent Biosciences, Inc. All other trademarks are property of their respective owners.
# # #
Media Contact: David Politis, [email protected], +1-801-556-8184
SOURCE: Path Fertility
View the original press release on ACCESS Newswire
M.Robinson--AT